Latest Regulatory News

Zenith Minerals has successfully raised A$3.5 million through a fully underwritten rights issue, positioning the company to fast-track exploration and resource growth at its key gold projects in Western Australia and Queensland.

Telix Pharmaceuticals has achieved a key milestone with its next-generation prostate cancer imaging agent, Gozellix, receiving a permanent HCPCS code from U.S. Medicare. This paves the way for broader reimbursement and market adoption starting October 2025.

Mithril Silver and Gold Limited has announced a C$10 million brokered private placement to fund expanded exploration at its Copalquin district project in Mexico. The raise includes an option for agents to increase the placement by 15%, underscoring strong investor interest.

Blackstone Minerals has launched a $2 million Share Purchase Plan at a 9% discount, running alongside a $22.6 million placement to institutional investors. Eligible shareholders in Australia and New Zealand can buy shares up to $30,000, supporting the company’s Mankayan Copper-Gold Project expansion.

Blackstone Minerals has completed a significant capital raise, issuing nearly 290 million new shares to bolster its financial position. The move follows regulatory compliance assurances and sets the stage for the company’s next growth phase.

Challenger Gold advances its Hualilan Gold Project with final metallurgical testwork underway, confirming heap leach processing can economically recover low-grade gold previously deemed waste. This development promises to expand the project’s scale and improve its economics ahead of the full-scale Pre-Feasibility Study.

Island Pharmaceuticals has accelerated its acquisition of the Galidesivir antiviral program from BioCryst Pharmaceuticals, adding a clinically advanced asset with significant US government backing and a promising regulatory pathway.

Blackstone Minerals has revealed significant surface copper and gold mineralisation adjacent to its flagship Mankayan project in the Philippines, setting the stage for expanded exploration and development.

Siren Gold reveals promising expansion and development prospects at its Sams Creek Project in New Zealand, with recent drilling uncovering new mineralised zones and a mining permit decision expected by year-end.

Orthocell Limited has reported a record FY2025 revenue of A$9.19 million, driven by strong sales of its nerve repair product Remplir™ in Australia and a promising US market launch following FDA clearance.

Verity Resources has appointed Dr Rick Gordon and Xirlatem Pty Ltd as strategic advisors to accelerate resource upgrades and expansion at its Monument Gold Project in Western Australia.

Arizona Lithium has secured A$8 million through the sale of its Big Sandy Lithium Project and Lithium Research Center, sharpening its focus on the Prairie Lithium Project in Canada, which is closer to production.